Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Genet ; 11: 577, 2020.
Article in English | MEDLINE | ID: mdl-32655619

ABSTRACT

The subchromosomal region 1q21.1 is one of the hotspots in the human genome for deletions and reciprocal duplications, owing to the existence of hundreds of segmental duplications. Recurrent deletions and duplications in this region are thought to be causative in patients with variable clinical manifestations. Based on the genomic locations, deletions and duplications at the 1q21.1 locus have been associated with distinguishable syndromes: chromosome 1q21.1 deletion syndrome, chromosome 1q21.1 duplication syndrome, and thrombocytopenia-absent radius (TAR) syndrome, which is partially due to deletions at the proximal 1q21.1 region. We report here diverse, recurrent deletions and duplications at the 1q21.1 locus in 36 patients from a cohort of 5,200 individuals. Among the 36 patients, 18 patients carry 1q21.1 deletions, nine individuals have reciprocal duplications at 1q21.1, two patients share an identical short deletion, and the remaining seven possess variable sizes of duplications at the proximal 1q21.1 region. Furthermore, we provide cytogenetic characterization and detailed clinical features for each patient. Notably, duplications at the proximal 1q21.1 region have not been associated with a defined disorder in publications. However, recurrent duplications at the proximal 1q21.1 region among the seven patients strongly suggested that the variants are likely pathogenic. The common phenotypical features of those disorders are also summarized to facilitate clinical diagnoses and genetic counseling.

2.
Am J Pathol ; 186(10): 2665-78, 2016 10.
Article in English | MEDLINE | ID: mdl-27497323

ABSTRACT

Herpes simplex virus type 1 (HSV-1) is a leading cause of neurotrophic keratitis characterized by decreased corneal sensation because of damage to the corneal sensory fibers. We and others have reported regression of corneal nerves during acute HSV-1 infection. To determine whether denervation is caused directly by the virus or indirectly by the elicited immune response, mice were infected with HSV-1 and topically treated with dexamethasone (DEX) or control eye drops. Corneal sensitivity was measured using a Cochet-Bonnet esthesiometer and nerve network structure via immunohistochemistry. Corneas were assessed for viral content by plaque assay, leukocyte influx by flow cytometry, and content of chemokines and inflammatory cytokines by suspension array. DEX significantly preserved corneal nerve structure and sensitivity on infection. DEX reduced myeloid and T-cell populations in the cornea and did not affect viral contents at 4 and 8 days post infection. The elevated protein contents of chemokines and inflammatory cytokines on infection were greatly suppressed by DEX. Subconjunctival delivery of neutralizing antibody against IL-6 to infected mice resulted in partial preservation of corneal nerve structure and sensitivity. Our study supports a role for the immune response, but not local virus replication in the development of HSV-1-induced neurotrophic keratitis. IL-6 is one of the factors produced by the elicited inflammatory response to HSV-1 infection contributing to nerve regression.


Subject(s)
Corneal Diseases/immunology , Herpesvirus 1, Human/physiology , Interleukin-6/immunology , Keratitis, Herpetic/immunology , Nerve Degeneration/etiology , Animals , Anti-Inflammatory Agents , Antibodies, Neutralizing/immunology , Chemokines/immunology , Cornea/pathology , Cornea/virology , Corneal Diseases/complications , Corneal Diseases/pathology , Corneal Diseases/virology , Cytokines/immunology , Dexamethasone/therapeutic use , Keratitis, Herpetic/complications , Keratitis, Herpetic/pathology , Keratitis, Herpetic/virology , Mice , Myeloid Cells/drug effects , Nerve Degeneration/complications , Nerve Degeneration/pathology , Nerve Degeneration/virology , T-Lymphocytes/drug effects
3.
J Immunol ; 197(4): 1262-75, 2016 08 15.
Article in English | MEDLINE | ID: mdl-27357149

ABSTRACT

HSV type 1 (HSV-1) is one of the leading etiologies of sporadic viral encephalitis. Early antiviral intervention is crucial to the survival of herpes simplex encephalitis patients; however, many survivors suffer from long-term neurologic deficits. It is currently understood that HSV-1 establishes a latent infection within sensory peripheral neurons throughout the life of the host. However, the tissue residence of latent virus, other than in sensory neurons, and the potential pathogenic consequences of latency remain enigmatic. In the current study, we characterized the lytic and latent infection of HSV-1 in the CNS in comparison with the peripheral nervous system following ocular infection in mice. We used RT-PCR to detect latency-associated transcripts and HSV-1 lytic cycle genes within the brain stem, the ependyma (EP), containing the limbic and cortical areas, which also harbor neural progenitor cells, in comparison with the trigeminal ganglia. Unexpectedly, HSV-1 lytic genes, usually identified during acute infection, are uniquely expressed in the EP 60 d postinfection when animals are no longer suffering from encephalitis. An inflammatory response was also mounted in the EP by the maintenance of resident memory T cells. However, EP T cells were incapable of controlling HSV-1 infection ex vivo and secreted less IFN-γ, which correlated with expression of a variety of exhaustion-related inhibitory markers. Collectively, our data suggest that the persistent viral lytic gene expression during latency is the cause of the chronic inflammatory response leading to the exhaustion of the resident T cells in the EP.


Subject(s)
Encephalitis, Herpes Simplex/virology , Ependyma/virology , Herpes Simplex/immunology , T-Lymphocytes/immunology , Virus Latency/physiology , Animals , Disease Models, Animal , Encephalitis, Herpes Simplex/immunology , Ependyma/immunology , Flow Cytometry , Herpesvirus 1, Human/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Real-Time Polymerase Chain Reaction
4.
J Virol ; 90(11): 5514-5529, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27030264

ABSTRACT

UNLABELLED: Correlates of immunologic protection requisite for an efficacious herpes simplex virus 1 (HSV-1) vaccine remain unclear with respect to viral pathogenesis and clinical disease. In the present study, mice were vaccinated with a novel avirulent, live attenuated virus (0ΔNLS) or an adjuvanted glycoprotein D subunit (gD-2) similar to that used in several human clinical trials. Mice vaccinated with 0ΔNLS showed superior protection against early viral replication, neuroinvasion, latency, and mortality compared to that of gD-2-vaccinated or naive mice following ocular challenge with a neurovirulent clinical isolate of HSV-1. Moreover, 0ΔNLS-vaccinated mice exhibited protection against ocular immunopathology and maintained corneal mechanosensory function. Vaccinated mice also showed suppressed T cell activation in the draining lymph nodes following challenge. Vaccine efficacy correlated with serum neutralizing antibody titers. Humoral immunity was identified as the correlate of protection against corneal neovascularization, HSV-1 shedding, and latency through passive immunization. Overall, 0ΔNLS affords remarkable protection against HSV-1-associated ocular sequelae by impeding viral replication, dissemination, and establishment of latency. IMPORTANCE: HSV-1 manifests in a variety of clinical presentations ranging from a rather benign "cold sore" to more severe forms of infection, including necrotizing stromal keratitis and herpes simplex encephalitis. The present study was undertaken to evaluate a novel vaccine to ocular HSV-1 infection not only for resistance to viral replication and spread but also for maintenance of the visual axis. The results underscore the necessity to reconsider strategies that utilize attenuated live virus as opposed to subunit vaccines against ocular HSV-1 infection.


Subject(s)
Cornea/pathology , Herpes Simplex Virus Vaccines/immunology , Herpesvirus 1, Human/immunology , Immunity, Humoral , Keratitis, Herpetic/immunology , Keratitis, Herpetic/prevention & control , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Cornea/immunology , Cornea/virology , Female , Herpes Simplex Virus Vaccines/administration & dosage , Herpesvirus 1, Human/pathogenicity , Humans , Immunization, Passive , Keratitis, Herpetic/virology , Lymphocyte Activation , Mice , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Viral Envelope Proteins/administration & dosage , Viral Envelope Proteins/immunology , Virus Shedding
5.
Graefes Arch Clin Exp Ophthalmol ; 253(10): 1721-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26047535

ABSTRACT

PURPOSE: To determine the utility of human organotypic cornea cultures as a model to study herpes simplex virus type 1 (HSV-1)-induced inflammation and neovascularization. METHODS: Human organotypic cornea cultures were established from corneas with an intact limbus that were retrieved from donated whole globes. One cornea culture was infected with HSV-1 (10(4) plaque-forming units), while the other cornea from the same donor was mock-infected. Supernatants were collected at intervals post-culture with and without infection to determine viral titer (by plaque assay) and pro-angiogenic and proinflammatory cytokine concentration by suspension array analysis. In some experiments, the cultured corneas were collected and evaluated for HSV-1 antigens by immunohistochemical means. Another set of experiments measured susceptibility of human three-dimensional cornea fibroblast constructs, in the presence and absence of TGF-ß1, to HSV-1 infection in terms of viral replication and the inflammatory response to infection as a comparison to the organotypic cornea cultures. RESULTS: Organotypic cornea cultures and three-dimensional fibroblast constructs exhibited varying degrees of susceptibility to HSV-1. Fibroblast constructs were more susceptible to infection in terms of infectious virus recovered in a shorter period of time. There were changes in the levels of select pro-angiogenic or proinflammatory cytokines that were dictated as much by the cultures producing them as by whether they were infected with HSV-1 or treated with TGF-ß1. CONCLUSION: Organotypic cornea and three-dimensional fibroblast cultures are likely useful for the identification and short-term study of novel antiviral compounds and virus replication, but are limited in the study of the local immune response to infection.


Subject(s)
Cornea/virology , Herpesvirus 1, Human/physiology , Keratitis, Herpetic/virology , Antigens, Viral/metabolism , Cells, Cultured , Corneal Keratocytes/metabolism , Corneal Keratocytes/virology , Corneal Neovascularization/metabolism , Corneal Neovascularization/virology , Cytokines/metabolism , Fluorescent Antibody Technique, Indirect , Humans , Keratitis, Herpetic/metabolism , Organ Culture Techniques , Tissue Donors , Transforming Growth Factor beta1/pharmacology , Vascular Endothelial Growth Factor C/metabolism , Viral Load , Virus Replication/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...